| Characteristics of H3K27M-mutant diffuse gliomas with a non-midline location S Guidara, A Seyve, D Poncet, C Leonce, PP Bringuier, A McLeer, ... | | 2024 |
| Olaparib in recurrent isocitrate dehydrogenase mutant high-grade glioma: A phase 2 multicenter study of the POLA Network I Esparragosa Vazquez, M Sanson, OL Chinot, M Fontanilles, R Rivoirard, ... Neuro-Oncology Advances 6 (1), 2024 | | 2024 |
| Classification moléculaire de 83 glioblastomes cérébelleux français et identification de sous-groupes pronostiques T Picart, D Poncet, M Barritault, L Bauchet, S Zouaoui, F Fina, J Honnorat, ... Morphologie 107 (359), 100627, 2023 | | 2023 |
| EPID-10. CNSONTRK STUDY: CLINICAL CHARACTERISTICS AND OUTCOME OF CENTRAL NERVOUS SYSTEM TUMORS HARBORING NTRK GENE FUSIONS AA Lamoureux, M Fisher, L Lemelle, E Pfaff, B De Wilde, S Pfister, ... Neuro-Oncology 25 (Supplement_5), v117-v117, 2023 | | 2023 |
| LBA54 Alkylating agent-based vs oxaliplatin-based chemotherapy in neuroendocrine tumours according to the O6-methylguanine-DNA methyltransferase (MGMT) status: a randomized … T Walter, T Lecomte, J Hadoux, P Niccoli, L Saban-Roche, E Gaye, ... Annals of Oncology 34, S1292-S1293, 2023 | 4 | 2023 |
| Bevacizumab as single agent in children and teenagers with optic pathway glioma P Calò, N Pianton, A Basle, A Vasiljevic, M Barritault, PA Beuriat, ... Cancers 15 (4), 1036, 2023 | 10 | 2023 |
| Ultrafast gene fusion assessment for nonsquamous NSCLC V Hofman, S Heeke, C Bontoux, L Chalabreysse, M Barritault, ... JTO Clinical and Research Reports 4 (2), 100457, 2023 | 14 | 2023 |
| Molecular characterization of adult tumors diagnosed as cerebellar glioblastomas identifies subgroups associated with prognosis T Picart, D Poncet, M Barritault, L Bauchet, S Zouaoui, J Guyotat, M Gabut, ... The American Journal of Surgical Pathology 47 (1), 131-144, 2023 | 3 | 2023 |
| Molecular genetics and immunostaining of relapsing inoperable meningiomas located at the base of skull (BS) or in frontal areas, before radiotherapy M Alshemeili, M Barritault, D Poncet, E Jouanneau, D Meyronet VIRCHOWS ARCHIV 481 (SUPPL 1), S55-S55, 2022 | | 2022 |
| EP11. 01-005 Ultra-Fast Gene Fusion Assessment as a Reflex Testing in Daily Clinical Practice for Advanced Non-small Cell Lung Cancer Patients V Hofman, S Heeke, C Bontoux, L Chalabreysse, M Barritault, ... Journal of Thoracic Oncology 17 (9), S511, 2022 | | 2022 |
| Étude anatomique et histologique d’une structure trop longtemps considérée à tort comme un simple ligament: le filum terminale T Picart, M Barritault, E Simon, C Barrey, D Meyronet, P Mertens Morphologie 106 (354), S1-S2, 2022 | | 2022 |
| Reply to Roesler et al. concerning the MEVITEM trial D Frappaz, M Barritault Neuro-oncology 24 (7), 1212-1212, 2022 | | 2022 |
| Clinical characteristics and outcome of a large cohort of patients with primary central nervous system (CNS) tumors and tropomyosin receptor kinase (TRK) fusion. AA Lamoureux, MJ Fisher, L Lemelle, E Pfaff, SM Pfister, D Sturm, ... Journal of Clinical Oncology 40 (16_suppl), 2052-2052, 2022 | | 2022 |
| HGG-11. Clinical characteristics and clinical evolution of a large cohort of pediatric patients with primary central nervous system (CNS) tumors and tropomyosin receptor kinase … AA Lamoureux, M Fisher, L Lemelle, E Pfaff, C Kramm, B De Wilde, ... Neuro-Oncology 24 (Supplement_1), i61-i62, 2022 | | 2022 |
| Gyriform infiltration as imaging biomarker for molecular glioblastomas E Mesny, M Barritault, C Izquierdo, D Poncet, A d’Hombres, J Guyotat, ... Journal of Neuro-Oncology 157 (3), 511-521, 2022 | 14 | 2022 |
| Central neurocytoma: a case report DR Purwaningrum, HR Sofyan, T Aninditha, TAS Ranakusuma Brain Tumor Research and Treatment 10 (Suppl), 2022 | | 2022 |
| Molecular characterization of adult cerebellar glioblastomas identifies distinct prognostic subgroups T Picart, D Poncet, M Barritault, J Pallud, L Bauchet, S Zouaoui, ... Brain Tumor Research and Treatment 10 (Suppl), 2022 | | 2022 |
| Faisabilité et utilité clinique d’une recherche systématique de transcrits de fusions oncogéniques par technique nCounter®(Nanostring) dans les cancers bronchiques non à … O Valet, C Masson, M Barritault, L Chalabreysse, M Darrason, ... Revue des Maladies Respiratoires Actualités 14 (1), 59-60, 2022 | | 2022 |
| Evaluating targeted next-generation sequencing assays and reference materials for NTRK fusion detection CB Chung, J Lee, M Barritault, PP Bringuier, Z Xu, WY Huang, A Beharry, ... The Journal of Molecular Diagnostics 24 (1), 18-32, 2022 | 19 | 2022 |
| The TeloDIAG: how telomeric parameters can help in glioma rapid diagnosis and liquid biopsy approaches P Billard, C Guerriau, C Carpentier, F Juillard, N Grandin, P Lomonte, ... Annals of Oncology 32 (12), 1608-1617, 2021 | 6 | 2021 |
François DucrayMD, Department of neuro-oncology, Lyon, France在 chu-lyon.fr 的电子邮件经过验证
